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ESTATE-OF-THE-ART PAPER891Platelet Biology and Response to Antiplatelet Therapy in WomenTracy Y. Wang, Dominick J. Angiolillo, Mary Cushman, Marc S. Sabatine, Paul F. Bray, Susan S. Smyth,
Harold L. Dauerman, Patricia A. French, Richard C. Becker
Wang and colleagues argue that women have been under-represented in cardiovascular studies
and that there may be important differences in platelet biology between the sexes. Previous
trials have shown both decreased responsiveness to antiplatelet agents and increased risks for
bleeding among women. A better understanding of the factors contributing to the observed
differences is needed, including studies of the frequency and expression of genetic
polymorphisms, the influence of inflammatory marker levels on atherothrombotic risk, and
the role of specific hormones in mediating platelet activation and function. Knowledge gained
about these mechanistic factors might inform the development of sex-specific antithrombotic
treatment regimens that confer optimized safety and efficacy.CLINICAL RESEARCH INTERVENTIONS IN HYPERTENSION
901enal Sympathetic Denervation Reduces
LVH in Patients With Resistant HypertensionMathias C. Brandt, Felix Mahfoud, Sara Reda, Stephan H. Schirmer, Erland Erdmann, Michael Böhm,
Uta C. Hoppe
Brandt and colleagues investigated the effect of catheter-based renal sympathetic denervation
(RD) on left ventricular hypertrophy (LVH), and systolic and diastolic function in patients
with resistant hypertension. A total of 46 patients underwent bilateral RD; and 18 patients
served as controls. RD produced significant, sustained reductions of systolic and diastolic
blood pressure (22.5/7.2 mmHg at 1 month and 27.8/8.8 mmHg at 6 months).
D significantly reduced mean interventricular septum thickness, LV mass index, and indices
f diastolic dysfunction, while no significant changes were seen in control patients. This study
hows that RD significantly reduces LV mass and improves diastolic function in patients with
esistant hypertension.
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913eta-Analysis Suggests That Trimetazidine Is
Beneficial in Patients With Chronic Heart FailureLei Zhang, Yizhou Lu, Hong Jiang, Liming Zhang, Aijun Sun, Yunzeng Zou, Junbo Ge
Trimetazidine (TMZ) shifts myocardial energy production from fatty acid oxidation to
glucose oxidation and has been demonstrated to be effective in stable angina pectoris. Zhang
and colleagues hypothesized that TMZ would be beneficial in patients with congestive heart
failure (CHF) and performed a meta-analysis to summarize the results of several small trials.
A total of 16 randomized trials involving 884 CHF patients were included. Hospitalization
for cardiac causes, but not all-cause mortality was reduced by TMZ treatment. TMZ therapy
was also associated with an increase in left ventricular ejection fraction and total exercise time,
and decreases in left ventricular dimensions. These results suggest the need for a larger clinical
trial of TMZ in patients with CHF.HEART RHYTHM DISORDERS
923ow Rates of CVA in Patients With
Incomplete LAA Closure With the Watchman DeviceJuan F. Viles-Gonzalez, Saibal Kar, Pamela Douglas, Srinivas Dukkipati, Ted Feldman, Rodney Horton,
David Holmes, Vivek Y. Reddy
The Watchman left atrial appendage (LAA) closure device is composed of a self-expanding
nitinol frame structure with fixation barbs and a permeable polyester fabric. It is designed to
isolate the LAA, but because of geometric variability of the LAA, ostium may not completely
seal in all patients. This substudy of the PROTECT AF trial compared clinical outcomes in
patients with peri-device leak to those with no leak. Serial transesophageal echocardiogram
(TEE) follow-up revealed that 1 of 3 implanted patients had at least some peri-device flow at
12 months. There was no evidence of an increased risk stroke in patients with a peri-device
leak. These data indicate that residual peri-device flow into the LAA with the Watchman
device is common, but is not associated with an increased risk of thromboembolism.HEART RHYTHM DISORDERS
930istopathologic Characterization of
Radiofrequency Ablation Lesions After PV IsolationMarcin Kowalski, Margaret M. Grimes, Francisco J. Perez, David N. Kenigsberg, Jayanthi Koneru,
Vigneshwar Kasirajan, Mark A. Wood, Kenneth A. Ellenbogen
The recovery of pulmonary vein (PV) conduction is thought to be responsible for the
recurrence of atrial fibrillation (AF) after catheter based PV isolation. Kowalski and colleagues
collected histopathologic and electrophysiologic findings from patients with AF recurrence
after PV isolation who underwent a subsequent surgical maze procedure. The major findings
of this study are as follows: 1) biopsies from PVs after isolation frequently show
nontransmural scar or gaps at the site of ablation; 2) PV conduction block may occur despite
nontransmural lesions along the ablation line; and 3) the histology of ablation lesions is
complex with evidence of reversible cellular injury. These results will help to define the
optimal techniques for catheter based PV isolation.Editorial Comment: Thomas J. McGarry, Sanjiv M. Narayan, p. 939
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942ardiosphere-Derived Cells Appear to Have Superior Paracrine Potency
and Myocardial Repair Efficacy to Other Stem Cell TypesTao-Sheng Li, Ke Cheng, Konstantinos Malliaras, Rachel Ruckdeschel Smith, Yiqiang Zhang, Baiming Sun,
Noriko Matsushita, Agnieszka Blusztajn, John Terrovitis, Hideo Kusuoka, Linda Marba´n, Eduardo Marba´n
Li and colleagues conducted a head-to-head comparison of different stem cell types for both
potency and functional myocardial repair in the same mouse model to determine which type
is most effective. Human cardiosphere-derived stem cells (CDCs), bone marrow-derived
mesenchymal stem cells (BM-MSCs), adipose tissue-derived mesenchymal stem cells
(AD-MSCs), and bone marrow mononuclear cells (BM-MNCs) were compared. In vitro,
CDCs showed the greatest myogenic differentiation potency, highest angiogenic potential,
and relatively high production of various angiogenic and antiapoptotic secreted factors. In
vivo, CDCs resulted in superior improvement of cardiac function. CDCs exhibit a more
balanced profile of paracrine factor production and functional benefit compared with other
stem cell types.PRE-CLINICAL RESEARCH
954lectroanatomic Remodeling of the
Left Stellate Ganglion After Myocardial InfarctionSeongwook Han, Kenzaburo Kobayashi, Boyoung Joung, Gianfranco Piccirillo, Mitsunori Maruyama,
Harry V. Vinters, Keith March, Shien-Fong Lin, Changyu Shen, Michael C. Fishbein, Peng-Sheng Chen,
Lan S. Chen
Retrograde axonal transport of nerve growth factors from infarcted myocardium to the left
stellate ganglion has been shown to stimulate nerve sprouting in the myocardium. Han and
colleagues measured stellate ganglionic nerve activity (SGNA) and vagal nerve activity (VNA)
with continuous recording in ambulatory dogs after myocardial infarction (MI) to determine
if there are also changes in the nerve’s electrical activity. After baseline monitoring, MI was
created by balloon occlusion, and the dogs were then continuously monitored for 2 months.
SGNA was increased 1.9-fold after MI compared with baseline, while VNA was 1.5 times
higher. These data indicate significant remodeling in the extracardiac autonomic and
sympathetic nerve activities after MI.Editorial Comment: Olujimi A. Ajijola, Kalyanam Shivkumar, p. 962
